Chemotherapy for operable gastric cancer: results of the Dutch randomised FAMTX trial. The Dutch Gastric Cancer Group (DGCG).

[1]  T. Hickish,et al.  Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  C. Lightdale,et al.  Neoadjuvant therapy of high-risk gastric cancer: a phase II trial of preoperative FAMTX and postoperative intraperitoneal fluorouracil-cisplatin plus intravenous fluorouracil. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  P. Fayers,et al.  Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial , 1996, The Lancet.

[4]  F. Caponigro,et al.  Neoadjuvant chemotherapy in locally advanced gastric-cancer - preliminary-results of a phase-ii trial with a modified famtx combination. , 1995, Oncology reports.

[5]  J. Hermans,et al.  Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients , 1995, The Lancet.

[6]  T. Hickish,et al.  A phase II study in advanced gastro-esophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluorouracil (ECF). , 1994, Annals of oncology : official journal of the European Society for Medical Oncology.

[7]  J. Pignon,et al.  Neoadjuvant chemotherapy in locally advanced gastric carcinoma--a phase II trial with combined continuous intravenous 5-fluorouracil and bolus cisplatinum. , 1994, European journal of cancer.

[8]  A. Axon,et al.  Gastric cancer: a curable disease in Britain. , 1993, BMJ.

[9]  C. V. D. van de Velde,et al.  Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  F. Muggia.  How to improve survival after diagnosis of gastric cancer? It's back to the drawing board. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  T. Conroy,et al.  Phase II study of sequential high-dose methotrexate (MTX) and 5-fluorouracil (F) alternated with epirubicin (E) and cisplatin (P) [FEMTX-P] in advanced gastric cancer. , 1993, Annals of oncology : official journal of the European Society for Medical Oncology.

[12]  L. Laine,et al.  Preoperative systemic chemotherapy followed by adjuvant postoperative intraperitoneal therapy for gastric cancer: a University of Southern California pilot program. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  P. Chandrasoma,et al.  Effects of preoperative chemotherapy on gastric adenocarcinomas. A morphologic study of 25 cases , 1992, Cancer.

[14]  C. Lightdale,et al.  FAMTX versus etoposide, doxorubicin, and cisplatin: a random assignment trial in gastric cancer. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  J. Ajani,et al.  Resectable gastric carcinoma. An evaluation of preoperative and postoperative chemotherapy , 1991, Cancer.

[16]  M. Buyse,et al.  Sequential high-dose methotrexate and fluorouracil combined with doxorubicin--a step ahead in the treatment of advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cooperative Group. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  J. Akoh,et al.  Improving results in the treatment of gastric cancer: An 11‐year audit , 1991, The British journal of surgery.

[18]  B. Berry,et al.  Cisplatin therapy for adenocarcinoma of the stomach. , 1991, Seminars in oncology.

[19]  A. Csendes.  Adenocarcinoma of the stomach: a review of 35 years and 1,710 cases. , 1991, World journal of surgery.

[20]  J. Sparano,et al.  Phase II Trial of Etoposide, Doxorubicin (Adriamycin), and Cisplatin (EAP Regimen) in Advanced Gastric Cancer , 1990, American journal of clinical oncology.

[21]  W. Allum,et al.  Early detection of gastric cancer. , 1990, BMJ.

[22]  H. Wilke,et al.  Phase II study with the combination etoposide, doxorubicin, and cisplatin in advanced measurable gastric cancer. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  J. Siewert,et al.  Preoperative chemotherapy in locally advanced and nonresectable gastric cancer: a phase II study with etoposide, doxorubicin, and cisplatin. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  H. O. Klein.  Long-term results with FAMTX (5-fluorouracil, adriamycin, methotrexate) in advanced gastric cancer. , 1989, Anticancer research.

[25]  B. Cady,et al.  Gastric Adenocarcinoma: A Disease in Transition , 1989 .